HomeNews

News
Burkina Faso R21 vaccine regulatory clearance

Oxford R21/Matrix-M™ malaria vaccine receives regulatory clearance for use in Burkina Faso

Health
Malaria
Vaccines
R21 vaccinations at Tanzania clinical site,Tom Wilkinson, University of Oxford

R21/Matrix-M™ malaria vaccine developed by University of Oxford receives regulatory clearance for use in Ghana

Malaria
Medical Sciences
Research
Vaccines
A child is vaccinated with the R21 malaria vaccine at Nanoro, Burkina Faso - credit Prof Katie Ewer

Malaria booster vaccine continues to meet WHO-specified 75% efficacy goal

Malaria
Research
Vaccines
Anopheles mosquito

Reducing children’s exposure to malaria in their early years substantially cuts the risk of hospitalisation.

Health
Malaria
Mathematical, Physical and Life Sciences
Research
Photo | Mosquito

Promising malaria vaccine enters final stage of clinical testing in West Africa

Research
Malaria
Vaccines
Photo | Technician working in the lab, Nanoro

Malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal

Malaria
Research
Vaccines
Drug resistant malaria spreading in South-East Asia

Drug resistant malaria spreading in South East Asia

Health
Research
Malaria
Getting rid of malaria possible, if we try something new

Getting rid of malaria possible, if we try something new

Malaria
Research
Health
Superbug’s spread to Vietnam threatens malaria control

Superbug’s spread to Vietnam threatens malaria control

Research
Health
Malaria
Red blood cell variation linked to natural malaria resistance

Red blood cell variation linked to natural malaria resistance

Research
Malaria
Health
Science

Pages